Royce & Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-451,037
| Closed | -$3.71M | – | 1039 |
|
|
2021
Q2 | $3.71M | Sell |
451,037
-106,400
| -19% | -$876K | 0.03% | 661 |
|
|
2021
Q1 | $4.99M | Sell |
557,437
-70,057
| -11% | -$627K | 0.03% | 598 |
|
|
2020
Q4 | $7.24M | Sell |
627,494
-74,000
| -11% | -$854K | 0.06% | 465 |
|
|
2020
Q3 | $7.3M | Buy |
701,494
+34,000
| +5% | +$354K | 0.08% | 374 |
|
|
2020
Q2 | $8.78M | Buy |
667,494
+91,000
| +16% | +$1.2M | 0.1% | 300 |
|
|
2020
Q1 | $4.54M | Buy |
576,494
+235,192
| +69% | +$1.85M | 0.06% | 400 |
|
|
2019
Q4 | $7.07M | Buy |
341,302
+16,294
| +5% | +$337K | 0.06% | 408 |
|
|
2019
Q3 | $4.45M | Buy |
325,008
+218,384
| +205% | +$2.99M | 0.04% | 507 |
|
|
2019
Q2 | $1.31M | Buy |
106,624
+91,600
| +610% | +$1.13M | 0.01% | 804 |
|
|
2019
Q1 | $187K | Buy |
+15,024
| New | +$187K | ﹤0.01% | 997 |
|
|
2018
Q4 | – | Sell |
-44,795
| Closed | -$838K | – | 1222 |
|
|
2018
Q3 | $838K | Hold |
44,795
| – | – | 0.01% | 945 |
|
|
2018
Q2 | $1.16M | Hold |
44,795
| – | – | 0.01% | 916 |
|
|
2018
Q1 | $1M | Hold |
44,795
| – | – | 0.01% | 967 |
|
|
2017
Q4 | $1.12M | Sell |
44,795
-5,205
| -10% | -$130K | 0.01% | 956 |
|
|
2017
Q3 | $1.21M | Hold |
50,000
| – | – | 0.01% | 915 |
|
|
2017
Q2 | $1.01M | Hold |
50,000
| – | – | 0.01% | 974 |
|
|
2017
Q1 | $1.35M | Buy |
+50,000
| New | +$1.35M | 0.01% | 935 |
|